glp 1 statistics GLP-1 Agonists Market Report 2025-2033, By Product, Molecule, and Geo GLP-1 Targeted Peptide Weight Loss

Roughly 15 million people, or about 12% of the U.S

Clinical and Molecular Hepatology

In its mildest form, inflammation in the gut may induce only brief discomfort or food intolerance, whereas in the extreme, gut inflammation can manifest as Crohns disease or ulcerative colitis, with life threatening implications

Introduction Diabetes is a chronic disease that occurs when the pancreas does not produce ade

Learn about the benefits and practical steps for transitioning patients from GLP-1 RAs to dual GLP-1/GIP receptor agonists, such as tirzepatide, to improve glycemic control in adults with type 2 diabetes.

Support your gut and mind with the VIMERGY GLP-1 Digestive Kit*